---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-021675"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:15:57.827378+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# InspireMD raises $58M via PIPE and warrant exercise; appoints Ray Cohen to board

## Summary
- PIPE gross proceeds $40.1M: 16.6M shares/pre-funded warrants at $2.42/share; led by OrbiMed and Marshall Wace.
- Warrant exercise yields $17.9M: 12.9M Series I warrants exercised at $1.3827, triggered by FDA PMA of CGuard Prime.
- Combined $58M to fund U.S. commercial launch of CGuard Prime; intended use includes sales/marketing, R&D, working capital.
- Raymond W. Cohen appointed to Board (Cl. 3), effective Aug 1; former CEO of Axonics (sold to BSX for $3.7B), brings MedTech scaling expertise.
- Directors Kathryn Arnold and Thomas Kester will not stand for reelection in 2026; expected resignations by Dec 31, 2025.

## SEC filing metadata
- accession: 0001641172-25-021675
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/0001641172-25-021675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000164117225021675/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-021675
- JSON: https://secwatch.observer/filing/0001641172-25-021675.json
- Plain text: https://secwatch.observer/filing/0001641172-25-021675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.